Tokyo, Apr 21, 2006 (JCN) - Dainippon Sumitomo Pharma announced on April 20 that it has received approval for AmBisome for Injection 50mg, a liposomal formulation of the antifungal agent amphotericin B, from the Ministry of Health, Labor and Welfare.
